INTRODUCTION AND OBJECTIVES: While recto-urethral fistula is a rare complication following salvage cryoablation for radiorecurrent prostate cancer, less is known about the development of recto-urethral fistula after primary whole gland cryoablation. We define the incidence and risk factors for recto-urethral fistula in a multicenter, centralized registry.
INTRODUCTION AND OBJECTIVES: While recto-urethral fistula is a rare complication following salvage cryoablation for radiorecurrent prostate cancer, less is known about the development of recto-urethral fistula after primary whole gland cryoablation. We define the incidence and risk factors for recto-urethral fistula in a multicenter, centralized registry.
METHODS: The Cryo-On-Line Data (COLD) Registry was queried for men undergoing primary whole gland cryotherapy between 1990 and 2014 who developed a recto-urethral fistula. Patient factors and disease parameters were correlated with the recto-urethral fistula using chi-squared tests for categorical variables and t-test for continuous variables. Variables with p<0.25 were entered into a binary logistic regression with stepwise backward elimination to determine the factors associated with formation of urethral fistula.
RESULTS: We identified 4,102 men who underwent primary whole gland cryotherapy between 1990 and 2014. Median age was 71 years (IQR:66-76). Median PSA was 6.5 (IQR: 4.8-9.8). Available Gleason Score included 8-10:500 pts, 7:1,194 pts and 6:1,601 while pretreatment clinical stage included T1:1539, T2:1,503 T3:328 and T4:20. 1,508 pts received neoadjuvant androgen deprivation. 805 cases were performed at academic centers and 3297 were performed in the private setting. Post-operative recto-urethral fistula was identified in 50 (1.2%) men. On univariate analysis, pre-operative Gleason score, pre-operative incontinence and post-operative urinary retention were statistically significant predictors for development of recto-urethral fistula. On multivariate analysis, postoperative urinary retention (OR 7.26, 95%CI 4.06-13.03, p<0.001) pre-operative Gleason score of 7 (OR 1.92, 95%CI 1.08-3.43, p¼0.027) and pre-operative incontinence (OR 2.95, 95% CI 1.12-7.76, p¼0.028) predicted urethral fistula.
CONCLUSIONS: In a large, mixed cohort of patients undergoing primary whole gland cryoablation for prostate cancer, the incidence of urethral fistula was very low at 1.2%. The strongest association was present in men with post-procedural urinary retention. Further study regarding instrumentation of the lower tract for retention following cryotherapy in the early post-operative setting is warranted.
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INTRODUCTION AND OBJECTIVES: Outcomes of salvage prostate cryosurgery in older men remain undefined. We evaluated oncological and functional outcomes after salvage full gland prostate cryoablation in men over age 75 years.
METHODS: We identified 923 men who underwent salvage full gland prostate cryoablation for recurrent prostate cancer after primary radiotherapy, including 240 (26%) > 75 years at time of surgery. Primary outcomes were progression-free survival (PFS) using Phoenix criteria and post-treatment biopsy status. Secondary outcomes included post-treatment urinary incontinence, erectile dysfunction (ED), rectal fistulae, and urinary retention.
RESULTS: Mean follow-up was 26 months (SDAE30). Compared to men 75 years, men > 75 years were more likely to have pre-treatment Gleason sum !7 disease (71% vs.63%, p¼0.03) and less likely to have undergone neoadjvuant androgen deprivation therapy (29% vs. 37%, p¼0.02) (Table 1 ). In Kaplan Meir analyses, there were no significant differences in 5-year PFS between groups: 61% versus 57% for men > 75 and 75 years, respectively (p¼0.43) (Figure 1 ). Post-treatment biopsy was positive in 34% versus 29% of men >75 years and 75 years, respectively (p¼0.5). Older men were more likely to have post-treatment urinary retention (23% versus 15%, p¼0.003). There were no significant differences in recto-urethral fistulae (3% versus 2%, p¼0.62), urinary incontinence (32% versus 30%, p¼0.48), or new onset ED (54% versus 49%, p¼0.63) between groups (Table 1) .
CONCLUSIONS: Salvage whole gland cryoablation of the prostate in men > 75 years is associated with robust progression-free survival and functional outcomes comparable to younger men. Prostate cryoablation should be considered in older men with recurrent disease after primary radiotherapy.
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